CHOP-14 protocol
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The efficiency of upfront consolidation with high‐dose chemotherapy/autologous stem‐cell transplantation (HDCT/ASCT) for newly…
Background:HDT with ASCT (HDT/ASCT) is an option as the upfront consolidation for poor-risk DLBCL. However, its role remains…
ZusammenfassungDas diffuse großzellige B‑Zell-Lymphom („diffuse large B‑cell lymphoma“ –DLBCL) ist das häufigste Non-Hodgkin…
7592 Background: Several studies have shown that the addition of rituximab (R) to CHOP (cyclophosphamide, doxorubicin…
Introduction: Early ASCT improves progression-free survival (PFS) but not overall survival (OS) in poor prognosis DLBCL treated…
ZusammenfassungDer Internationale Prognose-Index (IPI) erlaubt eine prognostische Einteilung von Patienten mit aggressiven…
8064 Background: In a previous pharmacokinetic study we had shown that the concomitant application of R-CHOP-14 does not achieve…
ZusammenfassungDer altersadaptierte Internationale Prognoseindex (IPI) erlaubt eine klinisch relevante Einteilung jüngerer…
The age-adjusted International Prognostic Index (IPI) allows the definition of clinically relevant subgroups in younger patients…
Biweekly application of rituximab in combination with biweekly CHOP (R-CHOP-14) results in a slow increase of rituximab serum…